Inhibrx Biosciences said head and neck cancer still faces major treatment gaps and called for expanded research to improve patient outcomes. The push, tied to W

Inhibrx Biosciences said head and neck cancer still faces major treatment gaps and called for expanded research to improve patient outcomes. The push, tied to World Head and Neck Cancer Day, also highlights the need for more awareness and investment.